NPS Pharmaceuticals is a global pharmaceutical company treating rare diseases specifically focusing upon gastrointestinal and endocrine disorders.
Gattex® as it’s known in the US or Revestive® in the EU is the company’s core marketed product, it is a injection for subcutaneous use for short bowel syndrome patients who are dependent on parenteral support. The company also has a secondary product in the pipeline called Natpara which is indicated for hyperparathyroidism and has been submitted to the FDA for approval. Natpara has been granted orphan status in the EU which was granted in the US back in 2007.
The name NPS stands for Natural Product Sciences, NPS Pharmaceuticals was established in 1986 by Doctors Hunter Jackson and Thomas Parks who at the time were researching the medical benefits of spider venom. This research although not very fruitful led to the company developing calcium channel blockers which in the following years attracted the attentions of big pharmaceutical company Pfizer. At this point the company’s profile had been officially raised so it decided to file for an IPO in 1994 which turned out to be a huge success for the company.
In 1999 the company acquired Allelix Pharmaceuticals in a move that would significantly expand its pool of budding scientists and add two key new products to its pipeline for osteoporosis and gastrointestinal disorders. this was the company's only major M&A to date.
By the early 2000’s the company employed over 100 people and was beginning to sign more licensing agreements for its own researched development products.
Today the company continues to develop new early stage candidates and it reaps the revenues from its successfully partnered products that are being licensed by companies such as Amgen, Nycomed and Ortho-McNeil.
This year in 2014 it celebrated 20 years since it first filed publicly on the stock exchange and it has been named as one of the top places to work in New Jersey by news journals.
Partnering to out-license
With a healthy pipeline of over 5 product candidates, NPS Pharmaceuticals will probably be expecting to partner these out to other companies who can take them to market in their respective countries. With the big pharma interest the company has had so far the new products will no doubt get this kind of interest too. See the section below on ways to contact NPS Pharmaceuticals.
NPS Pharmaceuticals is often present at a large number of partnering events throughout the year. Partnering events are a great place to meet lots of potential partners face to face in a short space of time.
Other events with NPS Pharmaceuticals presence include but are not limited to:
- BIO International Convention and Business Forum
- BioEurope / BioEurope Spring
For a full list of forthcoming partnering events where you could meet with NPS Pharmaceuticals in person visit Current Partnering’s Event calendar.
Contacting NPS Pharmaceuticals for partnering
NPS Pharmaceuticals can be contacted in relation to partnering through a number of channels. Here is a list of the most common channels:
Partnering events: face to face contact is generally considered the most effective form of contact. Partnering events not only allow face to face contact but also contact with multiple companies for the price of one flight and hotel reservation. This benefit makes partnering events the most cost effective method of making personal introductions as a start point for partnering discussions.
See Current Partnering’s event calendar for details of forthcoming events.
Direct contact: there are several sources of direct contact with NPS Pharmaceuticals’ business development team
- Phone: Picking up the phone and speaking with an individual is the best form of non-face to face contact as it allows your name and voice to be remembered and associated with an opportunity.
- Email: Sending an email is another good way of making contact. Ideally, research the individual responsible for the therapy/technology area being targeted and get in touch. This page on the NPS Pharmaceuticals Pharmaceuticals website has details for contacting NPS Pharmaceuticals Pharmaceuticals.
- LinkedIn: Business to business contact is increasingly taking place via LinkedIn, the global online networking channel.
Many of NPS Pharmaceuticals business development executives have LinkedIn profiles and can be found by viewing the company’s profile. Visit NPS Pharmaceuticals Linkedin Page.
Opportunity submission form: the least favourable channel but worth using if you do not have access to the other channels mentioned above. Visit the contacts page on NPS Pharmaceuticals website for potential partnering opportunities and general contact names.
NPS Pharmaceuticals partnering at Current Agreements
Full details on each deal can be found at Current Agreements (subscription required)
Or purchase report: Partnering Agreements with NPS Pharmaceuticals 2009-2014
No M&A activity for NPS Pharmaceuticals
Available reports from Current Partnering
Report: Partnering Agreements with NPS Pharmaceuticals 2009-2014
Report: Partnering Deals and Alliances with Big Biotech
Report: Big Biotech Partnering Yearbook 2013
Available resources for deal coverage for NPS Pharmaceuticals
Read: more on NPS Pharmaceuticals company profile, recent partnering, M&A and financing news and articles
Report: Finding Biopharma Licensing and Collaboration Partners
View: Current Partnering Insight Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering Insight M&A Scorecard – view top life science M&A deals by value
View: Current Partnering Insight Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering Insight Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk